142 related articles for article (PubMed ID: 27449273)
1. A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment.
Crist RC; Doyle GA; Kampman KM; Berrettini WH
Drug Alcohol Depend; 2016 Sep; 166():268-71. PubMed ID: 27449273
[TBL] [Abstract][Full Text] [Related]
2. Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.
Crist RC; Ambrose-Lanci LM; Vaswani M; Clarke TK; Zeng A; Yuan C; Ferraro TN; Hakonarson H; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Doyle GA; Lohoff FW; Berrettini WH
Drug Alcohol Depend; 2013 Jan; 127(1-3):122-8. PubMed ID: 22795689
[TBL] [Abstract][Full Text] [Related]
3. The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients.
Thomas PS; Nielsen EM; Spellicy CJ; Harding MJ; Ye A; Patriquin M; Hamon SC; Kosten TR; Nielsen DA
Psychiatr Genet; 2021 Jun; 31(3):88-94. PubMed ID: 33953123
[TBL] [Abstract][Full Text] [Related]
4. An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.
Crist RC; Clarke TK; Ang A; Ambrose-Lanci LM; Lohoff FW; Saxon AJ; Ling W; Hillhouse MP; Bruce RD; Woody G; Berrettini WH
Neuropsychopharmacology; 2013 Sep; 38(10):2003-10. PubMed ID: 23612435
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals.
Mannelli P; Patkar AA; Murray HW; Certa K; Peindl K; Mattila-Evenden M; Berrettini WH
Addict Biol; 2005 Sep; 10(3):261-8. PubMed ID: 16109588
[TBL] [Abstract][Full Text] [Related]
7. A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder.
Kranzler HR; Lynch KG; Crist RC; Hartwell E; Le Moigne A; Laffont CM; Andorn AC
Int J Neuropsychopharmacol; 2021 Feb; 24(2):89-96. PubMed ID: 32920647
[TBL] [Abstract][Full Text] [Related]
8. Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability.
Shumay E; Fowler JS; Wang GJ; Logan J; Alia-Klein N; Goldstein RZ; Maloney T; Wong C; Volkow ND
Transl Psychiatry; 2012 Mar; 2(3):e86. PubMed ID: 22832851
[TBL] [Abstract][Full Text] [Related]
9. A pilot trial of topiramate for the treatment of cocaine dependence.
Kampman KM; Pettinati H; Lynch KG; Dackis C; Sparkman T; Weigley C; O'Brien CP
Drug Alcohol Depend; 2004 Sep; 75(3):233-40. PubMed ID: 15283944
[TBL] [Abstract][Full Text] [Related]
10. Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.
Yuferov V; Butelman ER; Randesi M; Ott J; Kreek MJ
Neurosci Lett; 2022 Jan; 768():136364. PubMed ID: 34843875
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
[TBL] [Abstract][Full Text] [Related]
12. A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk.
Xu K; Seo D; Hodgkinson C; Hu Y; Goldman D; Sinha R
Transl Psychiatry; 2013 Aug; 3(8):e292. PubMed ID: 23962922
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and transcription factor binding associated with genotype at a pharmacogenetic variant in
Crist RC; Arauco-Shapiro G; Zhang A; Reiner BC; Berrettini WH; Doyle GA
Am J Drug Alcohol Abuse; 2021 Sep; 47(5):581-589. PubMed ID: 34407719
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Cocaine Selective Severity Assessment.
Kampman KM; Volpicelli JR; McGinnis DE; Alterman AI; Weinrieb RM; D'Angelo L; Epperson LE
Addict Behav; 1998; 23(4):449-61. PubMed ID: 9698974
[TBL] [Abstract][Full Text] [Related]
16. Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.
Jones JD; Luba RR; Vogelman JL; Comer SD
Am J Addict; 2016 Jan; 25(1):41-8. PubMed ID: 26692286
[TBL] [Abstract][Full Text] [Related]
17. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.
Lohoff FW; Weller AE; Bloch PJ; Nall AH; Ferraro TN; Kampman KM; Pettinati HM; Oslin DW; Dackis CA; O'Brien CP; Berrettini WH
Neuropsychopharmacology; 2008 Dec; 33(13):3078-84. PubMed ID: 18704099
[TBL] [Abstract][Full Text] [Related]
18. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence.
Smelson D; Yu L; Buyske S; Gonzalez G; Tischfield J; Deutsch CK; Ziedonis D
Am J Addict; 2012; 21(5):411-5. PubMed ID: 22882391
[TBL] [Abstract][Full Text] [Related]
19. Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials.
Singh M; Keer D; Klimas J; Wood E; Werb D
Addiction; 2016 Aug; 111(8):1337-46. PubMed ID: 26826006
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
